Introduction
Mebendazole has a wide spectrum of action and high activity against the helminths, particularly Ascaris lumbricoides, Trichuris trichiura, taenia, enterobius, hookworm, and to a lesser degree Hymenolepis spp.1-3 It also has a definite effect against strongyloides.4
In Birmingham many immigrant children from all parts of the globe are examined before they enter school, and faecal examinations have shown that they are often infested. 5 The treatment of these children, however, has proved virtually impossible because of the lack of satisfactory drugs (the worm species commonly found were not particularly sensitive to a single agent), because many of the immigrants lacked general practitioners to take over their treatment, and because a language barrier made adequate communication very hard. Attempts were made to organize a single treatment session at a hospital when results of the faecal examinations were known, but the outcome of any treatment remained completely unknown because few of the treated patients ever returned to the hospital clinic. We report here the results of a trial of mebendazole (performed under D.H.S.S. Licence) in a small series of children of 5-14 years old. Reports had suggested that the drug was only slightly absorbed (5-10%) and no toxicity had been shown in extensive foreign studies. 2 
Methods
Children of both sexes aged [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] years were examined at the school clinic and brought with them a faecal specimen. As part of the examination they were given a Heaf test, and they returned seven days later for the test to be read, by which time the results of faecal examination were available. The modified formol-ether method6 was used for detecting ova. If helminth ova were found the parent or guardian was given six 100-mg tablets of mebendazole with instructions to give one tablet to the child night and morning for three days; the first dose was given at the clinic. Between seven and 21 days later (median 14 days) a second faecal specimen was obtained by a home visit (M.V.P.P.) and inquiries were made about any possible ill effects of the drug. Results of the second examination were then collated with the first to assess drug efficacy. If ova were present in the second specimen which had not been detected in the first we assumed that they had been missed on first examination, as cross-infestation and its manifestation in so short a time is unlikely in Britain. The formolether method gives a positive result on a single examination in about 75% of infestations. The finding of Giardia lamblia cysts in faeces is capricious and stools may be repeatedly negative in spite of known infection. Nevertheless 25 children who had cysts of G. lamblia only were also treated. No attempt was made to control the trial with untreated cases.
Results
Eighty-five children harbouring helminths submitted a follow-up faecal specimen and were believed to have taken the tablets. Of these 65 (76%) seemed to have been dewormed. Of those with a single infestation the cure rates were ascaris 100%, trichuris 91 %, hookworm 94%, and hymenolepis 50% (see table) . Only a few children had multiple infestations. All four children with ascaris and trichuris were cured, as were all three with ascaris, trichuris, and hookworm. Of the three with ascaris and hookworm one was cured, of the three with trichuris and hookworm one was cured, but of the seven with hookworm and hymenolepsis only one was cured. The large variations in percentage cures probably reflected a large standard error (i 27% in the cases of mixed ascaris/hookworm and trichuris/hookworm infestations) rather than a real difference in the drug's effectiveness. This view is to some extent supported by the fact that the cure rate for the triple infestation ascaris/trichuris/hookworm was 100%. Except for hymenolepis the cure rates were most promising and similar to those of the single infestation group. important result as many children suffer because of hookworms. Our results suggest that giardia carriage may be influenced by mebendazole. In Brazil, however, Souzaet al.1 were unable to show any effect on this parasite, but their findings may have been biased by reinfestation due to a heavy load of the parasite in the environment and poor hygienic conditions. Clearly, our findings require confirmation, for though mebendazole would not be the drug of choice for treating infestation due to giardia alone (metronidazole would be better) it would be an advantage to know that deworming with mebendazole might incidentally eradicate G. lamblia.
While in the U.K. we neither have nor expect to have a worm problem such as exists in some parts of the world we can agree with Penia Chavarria et al.,4 who treated Costa Rican patients with mebendazole in considering the drug "as a public health tool in mass therapy for helminth control." Certainly, mebendazole should prove useful in Britain for treating people with multiple infestations.
Introduction
All the symptoms in the acute phase of hereditary hepatic porphyria are probably due to damage to the autonomic, peripheral, or central nervous system.' In severe porphyria, neuropathy is a typical and well-known finding. Because of the intermittent character of hereditary hepatic porphyria, however, most patients are symptomless almost all their lives, showing only an increased excretion of porphyrins and their precursors. In lead poisoning, which resembles porphyria,2 disturbances in nerve conduction without clinical symptoms have been noted.3 The purpose of this study was to find whether similar changes occur in latent acute intermittent porphyria and latent variegate porphyria.
